Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,594.00
-58.70 (-3.55%)
Mar 30, 2026, 3:30 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 302.49 billion as of March 30, 2026. Its market cap has increased by 62.94% in one year.
Market Cap
302.49B
Enterprise Value
315.38B
Revenue
88.50B
Ranking
n/a
PE Ratio
34.76
Stock Price
1,594.00
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 302.49B, an increase of 17.72%. That is a compound annual growth rate of 10.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 313.33B | 21.13% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |
| Ajanta Pharma | 350.67B |
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |